Table 2.

Hazard ratio of any grade 3–5 chronic health condition for 583 2-year survivors of autologous BMT for lymphoma performed before age 40 years.

	All BMT recipients			Hodgkin lymphoma			Non-Hodgkin lymphoma
Variable	HR	95% CI	p value	HR	95% CI	p value	HR	95% CI	p value
Age at BMT (years)
≤21	Ref			Ref
22–30	1.46	0.79–2.72	0.23	1.22	0.61–2.43	0.58
>30	2.31	1.27–4.19	0.01	2.16	1.12–4.18	0.02
Race/ethnicity
Non-Hispanic white				Ref			Ref
Black				0.53	0.24–1.14	0.10	3.79	1.88–7.67	0.0002
Hispanic				1.59	0.91–2.79	0.11	1.50	0.88–2.56	0.14
Other				1.25	0.58–2.66	0.57	0.75	0.25–2.29	0.61
Year of BMT
<1990	Ref						Ref
1990–1999	0.73	0.48–1.09	0.13				0.58	0.32–1.06	0.08
≥2000	0.54	0.34–0.85	0.01				0.34	0.18–0.64	0.001
Stem cell source
Bone marrow				Ref
PBSC				0.66	0.42–1.05	0.08
Pre-BMT radiotherapy
No	Ref			Ref			Ref
Yes	1.52	1.13–2.03	0.01	1.47	1.00–2.18	0.05	1.77	1.13–2.76	0.01